Chestnut Hill, MASSACHUSETTS
2025
Biotechnology
2
$7.47M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-10-13 | New offering first sale 2026-10-07 | $2.63M | $2.70M | details · SEC filing |
| 2025-08-07 | New offering first sale 2025-07-25 | $4.84M | $6.34M | SEC filing |
Watch Axelyf, Inc.
Get an email when Axelyf, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Axelyf, Inc.?
Who to contact
- Orn Almarsson — Executive Officer, Director, Promoter
- Leslie Williams — Director
- Arni Blondal — Director
- Round: Form D filed 2026-10-13
- Amount sold: $2.63M
- Industry: Biotechnology
- Founded: 2025
- Based: Chestnut Hill, MASSACHUSETTS
People listed
- Orn Almarsson — Executive Officer, Director, Promoter
- Leslie Williams — Director
- Arni Blondal — Director
- Filing: Form D filed 2026-10-13
- Amount sold: $2.63M
- Industry group: Biotechnology
- Year formed: 2025
- Based: Chestnut Hill, MASSACHUSETTS
- Entity type: Corporation
We'll show it in your MentionFox inbox when Axelyf, Inc. raises, hires or launches. No email unless you switch it on.
Watch Axelyf, Inc. →Want the whole picture on Axelyf, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Axelyf, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Axelyf, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Axelyf, Inc.'s own filings with the SEC. The people those filings name are on the team page.